Comments
Loading...

OS Therapies Analyst Ratings

OSTXAMEX
Logo brought to you by Benzinga Data
$1.64
-0.02-1.20%
At close: -
Q1 2025 Earnings were released on Fri May 16th, before the market open
Consensus Rating1
Buy
Highest Price Target1
$21.00
Lowest Price Target1
$15.00
Consensus Price Target1
$18.75

OS Therapies Analyst Ratings and Price Targets | AMEX:OSTX | Benzinga

OS Therapies Inc has a consensus price target of $18.75 based on the ratings of 4 analysts. The high is $21 issued by EF Hutton on October 3, 2024. The low is $15 issued by Maxim Group on January 16, 2025. The 3 most-recent analyst ratings were released by D. Boral Capital on May 15, 2025, April 22, 2025, and April 7, 2025, respectively. With an average price target of $20 between D. Boral Capital, there's an implied 1069.59% upside for OS Therapies Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
3
Feb
1
Mar
3
Apr
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

D. Boral Capital
Lake Street
Maxim Group
EF Hutton

1calculated from analyst ratings

Analyst Ratings for OS Therapies

Buy NowGet Alert
05/15/2025Buy Now1069.59%D. Boral Capital
Jason Kolbert42%
$20 → $20MaintainsBuyGet Alert
04/22/2025Buy Now1069.59%D. Boral Capital
Jason Kolbert42%
$20 → $20MaintainsBuyGet Alert
04/07/2025Buy Now1069.59%D. Boral Capital
Jason Kolbert42%
$20 → $20MaintainsBuyGet Alert
04/02/2025Buy Now1011.11%Lake Street
Chad Messer34%
→ $19Initiates → BuyGet Alert
03/31/2025Buy Now1069.59%D. Boral Capital
Jason Kolbert42%
$20 → $20MaintainsBuyGet Alert
02/24/2025Buy Now1069.59%D. Boral Capital
Jason Kolbert42%
$20 → $20MaintainsBuyGet Alert
02/20/2025Buy Now1069.59%D. Boral Capital
Jason Kolbert42%
$20 → $20MaintainsBuyGet Alert
02/04/2025Buy Now1069.59%D. Boral Capital
Jason Kolbert42%
$20 → $20MaintainsBuyGet Alert
01/30/2025Buy Now1069.59%D. Boral Capital
Jason Kolbert42%
$20 → $20MaintainsBuyGet Alert
01/16/2025Buy Now777.19%Maxim Group
Jason McCarthy42%
$8 → $15MaintainsBuyGet Alert
01/15/2025Buy Now1069.59%D. Boral Capital
Jason Kolbert42%
$20 → $20MaintainsBuyGet Alert
11/26/2024Buy Now367.84%Maxim Group
Jason McCarthy42%
→ $8Initiates → BuyGet Alert
10/03/2024Buy Now1128.07%EF Hutton
Jason Kolbert42%
$21 → $21MaintainsBuyGet Alert
09/16/2024Buy Now1128.07%EF Hutton
Jason Kolbert42%
$21 → $21MaintainsBuyGet Alert
09/03/2024Buy Now1128.07%EF Hutton
Jason Kolbert42%
→ $21Initiates → BuyGet Alert

FAQ

Q

What is the target price for OS Therapies (OSTX) stock?

A

The latest price target for OS Therapies (AMEX:OSTX) was reported by D. Boral Capital on May 15, 2025. The analyst firm set a price target for $20.00 expecting OSTX to rise to within 12 months (a possible 1119.51% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for OS Therapies (OSTX)?

A

The latest analyst rating for OS Therapies (AMEX:OSTX) was provided by D. Boral Capital, and OS Therapies maintained their buy rating.

Q

When was the last upgrade for OS Therapies (OSTX)?

A

There is no last upgrade for OS Therapies

Q

When was the last downgrade for OS Therapies (OSTX)?

A

There is no last downgrade for OS Therapies.

Q

When is the next analyst rating going to be posted or updated for OS Therapies (OSTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OS Therapies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OS Therapies was filed on May 15, 2025 so you should expect the next rating to be made available sometime around May 15, 2026.

Q

Is the Analyst Rating OS Therapies (OSTX) correct?

A

While ratings are subjective and will change, the latest OS Therapies (OSTX) rating was a maintained with a price target of $20.00 to $20.00. The current price OS Therapies (OSTX) is trading at is $1.64, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch